Top Story

FDA grants orphan drug designation to Reolysin for fallopian tube cancer

March 2, 2015

The FDA today granted orphan drug designation to pelareorep for the treatment of fallopian tube cancer, according to a press release from the drug’s manufacturer.

Pelareorep (Reolysin, Oncolytics Biotech) has been analyzed in two sponsored clinical studies in patients with cancer of the fallopian tube.

FDA NewsDrug Pipeline

FDA grants 'breakthrough' status to EBV-CTL for EBV-associated lymphoproliferative disease

March 2, 2015
The FDA today granted breakthrough therapy designation to EBV-CTL for the treatment of patients with rituximab-refractory, Epstein-Barr virus-associated…
Meeting News Coverage

HIV did not affect HCC recurrence or survival after LT

March 2, 2015
Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster…
Industry News

Novartis completes acquisition of GSK oncology portfolio

March 2, 2015
Novartis completed its acquisition of GlaxoSmithKline’s oncology portfolio for an aggregate cash consideration of $16 billion, the companies announced…

Boehringer Ingelheim files BLA for antidote to dabigatran

March 2, 2015
Boehringer Ingelheim announced that it has submitted a biologics license application to the FDA requesting an accelerated approval pathway for idarucizumab, an antidote…
More News Headlines »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Video
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »